Optimizing management of colorectal hepatic metastases: Now and in the future

European Journal of Surgical Oncology

Volumn 40, Issue 9, 2014, Pages 1033-1035

  Uppal, A ^a   Weichselbaum, R R ^a   Posner, M C ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Colorectal cancer; Liver resection; Oligometastases

Indexed keywords

COLORECTAL CANCER; LIVER RESECTION; OLIGOMETASTASES;

CARCINOMA; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; METASTASECTOMY; NEOADJUVANT THERAPY;

EID: 84905905125     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2014.03.004     Document Type: Editorial

References (10)

1. W. Schmiegel, A. Reinacher-Schick, and D. Arnold et al. Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group Ann Oncol 24 6 2013 Jun 1580 1587 Oxford University Press
2. Y. Fong, J. Fortner, R.L. Sun, M.F. Brennan, and L.H. Blumgart Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg 230 3 1999 Sep 309 318 [discussion 318-21]
3. R. Adam, A. De Gramont, and J. Figueras et al. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus 17 10 2012 1225 1239
4. R. Adam, V.R. Delvart, and G.R. Pascal et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy Transactions of the Meeting of the American Surgical Association CXXII 2004 242 256
5. R.J. de Haas, D.A. Wicherts, E. Flores, D. Azoulay, D. Castaing, and R. Adam R1 resection by necessity for colorectal liver metastases Transactions of the Meeting of the American Surgical Association 126 2008 269 280
6. I. Fumagalli, J.-E. Bibault, and S. Dewas et al. A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases Radiat Oncol Lond Engl 7 2012 164 BioMed Central
7. B. Nordlinger, H. Sorbye, and B. Glimelius et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet 371 9617 2008 Mar 1007 1016
8. E. Mitry, A.L.A. Fields, and H. Bleiberg et al. Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials J Clin Oncol 26 30 2008 Oct 20 4906 4911
9. R. Araujo, M. Gonen, and P. Allen et al. Comparison between perioperative and postoperative chemotherapy after potentially curative hepatic resection for metastatic colorectal cancer Ann Surg Oncol 20 13 2013 Jul 30 4312 4321 Springer US
10. Y.A. Lussier, N.N. Khodarev, and K. Regan et al. Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific micrornas PLoS ONE 7 12 2012 e50141